Both in Pharmaceuticals
Aquestive Therapeutics vs Sagimet Biosciences Inc. Series A
Over the past year AQST returned −17.3% and SGMT returned +34.8%; their daily moves had a correlation of 0.11.
AQST −17.3% SGMT +34.8%Growth of $1, one year, split-adjusted
| Metric | AQST | SGMT |
|---|---|---|
| Price | $4.67 | $9.33 |
| Market cap | $586.1M | $579.9M |
| Today | −1.68% | −6.14% |
| 1 month | −7.0% | −11.6% |
| 6 months | +15.6% | +105.1% |
| Year to date | −27.7% | +57.6% |
| 1 year | −22.0% | +27.1% |
| Revenue growth (YoY) | +38.1% | — |
| Gross margin | 70.9% | — |
| Net margin | −165.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 10.8× | — |
| Net cash | $47.8M | $240.1M |
| Dividend yield | — | — |
| Volatility (60d) | 48.4% | 69.4% |
| Short % of float | 25.2% | 36.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).